A comprehensive evaluation of de novo metastatic breast cancer trends by subtype from the Dallas Metastatic Cancer Study by Hannah L. Chang, Meng Cao, Mir Lim, Anna Moscowitz, Ang Gao, Ariana Weiss, Ariel Brown, Danielle Spanbauer, Giselle Uwera, Jaeyoung Oh, Jonathan Ladner, Nathaniel Wu, Priscilla Okanlawon, Reynaldo Olivo, Ruchita Iyer, Yemariamwork Engidaw, Sangeetha M. Reddy, Heather L. McArthur, Lily Xu, Sakshi Mohta, Julia Maues, Christine Hodgdon, Luis Chinea, Katherine Lei, Shao-Po Huang, Rani Bansal, Isaac S. Chan

Get full text

Nivolumab plus low-dose ipilimumab in hypermutated HER2-negative metastatic breast cancer: a phase II trial (NIMBUS) by Romualdo Barroso-Sousa, Jorge Gomez Tejeda Zanudo, Tianyu Li, Sangeetha M. Reddy, Leisha A. Emens, Thomas M. Kuntz, Carolina Alves Costa Silva, Saud H. AlDubayan, Hoyin Chu, Beth Overmoyer, Paulina Lange, Molly K. DiLullo, Meagan Montesion, Julie Kasparian, Melissa E. Hughes, Victoria Attaya, Ameer Basta, Nancy U. Lin, Nabihah Tayob, Rinath Jeselsohn, Elizabeth A. Mittendorf, Sara M. Tolaney

Get full text